News from the healthcare data industry
Participating providers are working with Epic to kick off the first stage of the Life Sciences program: study feasibility and clinical trial matchmaking VERONA, Wis., Sept. 14, 2022 /PRNewswire/ — Epic announces...
OTTAWA, ON, Sept. 14, 2022 /PRNewswire/ – A new book being published by Replica Analytics, an Aetion company, offers a complete and contemporary risk assessment methodology for accurately measuring and effectively managing...
TORONTO (PRWEB) SEPTEMBER 14, 2022 For real-world data (RWD) to be useful at scale to drive business insights, it often needs to be deemed as ‘quality’ data. Transforming RWD into a...
Available for licensing and analytics, these datasets enable faster access to research-grade IBD condition data, including longitudinal outcomes BOSTON, Sept. 14, 2022 /PRNewswire/ — OM1, a leading real-world data, outcomes and technology company...
The new General Manager joins CEO Curt Medeiros to further strengthen Ovation’s executive leadership team September 13, 2022 09:10 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ovation, a next-generation clinicogenomic data...
TUESDAY SEPTEMBER 13TH, 2022 WellSpan Health, Centura Health, MetroHealth, and Virtua Health join Truveta. Four leading healthcare providers — WellSpan Health, Centura Health, MetroHealth, and Virtua Health — have joined...
The nation’s largest COVID-19 Research Database and advanced data-analysis platform to power the early identification of patients at risk of developing chronic kidney disease FORT LAUDERDALE, Fla. and SAN FRANCISCO, Sept. 13, 2022 /PRNewswire/ —...
Our Future Health’s trusted research environment will collect information from millions of volunteers and provide tools to transform the prevention, detection, and treatment of diseases September 12, 2022 08:03 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS...
September 12, 2022 06:30 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Today Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, and Relay Therapeutics (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the...
SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) — The Broad Institute of MIT and Harvard (Broad), a leader in advancing human health through genomic research, and Datavant, the leader in helping organizations...